technology commercialization
AtlasXomics, EpiCypher Partner to Commercialize Spatial Epigenomics Assays
The companies will jointly develop spatial epigenomics assays using CUT&Tag reagents and antibodies from EpiCypher on AtlasXomics' DBiT-seq platform.
As part of a lawsuit against 10x Genomics, Vizgen has alleged that Harvard improperly gave spinout ReadCoor an exclusive license to tech developed under an NIH grant.
CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients
The test will identify more than 100 pathogens, as well as drug resistance in viruses and bacteria.
Developed by researchers at Yale University, the method, called deterministic barcoding in tissue sequencing, can map thousands of genes at 10 micron resolution.
In their first conference call with investors, PacBio's new CEO and CFO laid out a strategic plan for the company as it weathers the COVID-19 pandemic.
Feb 21, 2020
Jan 15, 2020
IARPA Commits $48M to DNA Data Storage
Oct 28, 2019
Oct 15, 2019
Nov 26, 2018
PerkinElmer Vanadis NIPT Receives CE-IVD Mark
Sep 5, 2018
Mar 21, 2018
Mar 3, 2017